Venous Thromboembolism Events With COVID-19 in an Intensive Care Unit
COVID-19 ICU patients exhibited distinct phenotypic traits that suggested standard VTE prophylaxis is insufficient in this population.
Thrombotic Disorders
Deep Vein Thrombosis Detection in Patients With Hemophilia A Undergoing Total Knee Arthroplasty
A prospective, single-center study aimed to determine the prevalence of DVT after TKA among patients with hemophilia A and found that contrast-enhanced CT led to better detection compared with ultrasound.
MPN Genomic Calculator Performs Well in Real-Life Cohort of Patients With Essential Thrombocythemia
The MPN Genomic Calculator uses clinical, laboratory, and genomic characteristics of patients with MPN to estimate their clinical outcomes.
Caplacizumab Safe, Effective for Acquired Thrombotic Thrombocytopenic Purpura
Caplacizumab appears to be safe and effective among patients with acquired thrombotic thrombocytopenic purpura treated in the real-world setting.
Comparison of Early and Late Transplant-Associated Thrombotic Microangiopathy
Although etiologies and traits of early and late thrombotic microangiopathy may vary, outcomes for both patient populations are similarly unfavorable.
Thrombosis and Iron Deficient Anemia: Determining Trends in Thrombotic Complications
Although the association between thrombocytosis in iron deficiency anemia is understood, researchers studied the risk for thrombotic complications.
Series of COVID-19 Autopsies Reveal Platelet-Rich Multiorgan Thrombi
In a number of COVID-19 autopsies, thrombosis of multiple organs was a prominent feature, regardless of timing of disease course and anticoagulation status.
Extracellular Histones in Patients With Cerebral Malaria Linked to Blood-Brain Barrier Breakdown, Thrombosis
Surface accumulation of parasite histones may be linked to coagulation activation and blood-brain barrier breakdown in children with cerebral malaria.
BSH Guideline Update for Assays Used in Hemostasis and Thrombosis
The British Society of Haematology released updates to 2 previous guidelines to help clinical laboratories with assays for coagulant diagnostic services.
Ropeginterferon Appears to Improve Polycythemia Vera Symptoms
The purpose of this study was to determine if a cytoreductive agent could provide additional efficacy to treat blood hyperviscosity.
-
Loading...
-
Loading...
Next post in EHA25 Virtual Congress
